Speciality: Oncology
Description:
A warm welcome to all the medical professionals in this interesting session of oropharyngeal cancer in association with HPV status of the patients. In this webinar, the speaker, Dr. Ashish M Kaushal, and Dr. Tejinder Singh has shared the important facts associated with head and neck cancer.
Oropharyngeal cancers are common in men as smoking is one of the primary reasons for having this disease. Also, being infected with human papillomavirus (HPV) can increase the risk of oropharyngeal cancer. Signs and symptoms of oropharyngeal cancer include a lump in the neck and a sore throat
HPV status is associated with the occurrence of cancer at the back of the throat, including the base of the tongue and tonsils. About 70% of oropharyngeal cancers occur in HPV positive individuals. However, HPV negative patients can also have head and neck cancers. Learn more about them through case studies in this session
Therefore, listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
1.
'CDC Must Be Investigated'; David Lynch, Bob Uecker Die; Nasal Epinephrine Warning
2.
Two-part prodrug system activates immune attack only in tumor's unique environment
3.
CD39 Blockade Shows Potential in Early-Stage Lung Cancer
4.
Medicaid expansion tied to smaller declines in early-stage cancer detection
5.
Glofitamab Regimen Improves Survival in DLBCL
1.
Inside Oncology Trials: From Protocol to Progress in Cancer Research and Care
2.
Introduction to Immune Thrombocytopenic Purpura
3.
Iron Deficiency Anemia: Challenges in Diagnosis and Treatment
4.
The Benefits and Risks of Cervical Conization
5.
The Future is Now: Navigating the Precision Revolution in Oncology Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Current Scenario of Cancer- The Incidence of Cancer in Men
2.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII
3.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
4.
Dissecting Molecular differences between EGFR Exon 19 deletion and Exon 21 L858R Mutations
5.
Thromboprophylaxis In Medical Settings
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation